Transgene, NEC, BostonGene collaborate for ovarian and head & neck cancers trials
World | News | 0 Comment | 07 Oct, 2020
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, a leader...Read more
Research on thirst wins 2020 Eppendorf & Science prize
World | News | 0 Comment | 07 Oct, 2020
The American scientist Christopher Zimmerman, Ph.D., Postdoctoral Fellow at the Princeton Neuroscience Institute in Prin...Read more
Mercy Ships announces world's largest NGO hospital ship
World | News | 0 Comment | 06 Oct, 2020
US-based Mercy Ships that uses hospital ships to deliver free, world-class healthcare services, capacity building, and s...Read more
Hepatitis C virus discovery gets Nobel Prize 2020 in Medicine
World | News | 0 Comment | 05 Oct, 2020
The Nobel Assembly at Karolinska Institutet has decided to award the 2020 Nobel Prize in Physiology or Medic...Read more
Healthcare consulting firm Nordic expands its reach to Europe and Asia
World | News | 0 Comment | 05 Oct, 2020
Nordic, a top-rated healthcare consulting firm, on 2 Oct 2020 announced its acquisition of Tasman Global, a healthc...Read more
APAC Health and Finance Ministers commit to building stronger health systems
World | News | 0 Comment | 02 Oct, 2020
Building on the learnings from the ongoing global COVID-19 pandemic, in mid-September, Ministers of Health and Fin...Read more
GVN's virus experts to identify promising advanced strategies to battle COVID-19
World | News | 0 Comment | 01 Oct, 2020
The Global Virus Network (GVN), a coalition of the world's leading medical and basic virology research centers working t...Read more
J&J initiates global Ph 3 trial of COVID-19 vaccine candidate
World | News | 0 Comment | 24 Sep, 2020
Johnson & Johnson has announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for i...Read more
The Lancet announces editorial policy changes post HCQ episode
World | News | 0 Comment | 23 Sep, 2020
The publication and subsequent retraction in June, 2020, of the article 'Hydroxychloroquine (HCQ) or chloroquine wi...Read more
World | Opinion | 0 Comment | 14 Sep, 2020
The COVID-19 pandemic has disrupted the traditional business models of companies. While digital transformation has been ...Read more
Dr. Sven Abend appointed to the Management Board of GELITA AG
World | News | 0 Comment | 14 Sep, 2020
GELITA AG, the global market leader in the field of gelatine and collagen peptides, appoints Dr. Sven Abend to the Execu...Read more
Fitbit receives regulatory clearance in US & Europe for ECG app
World | News | 0 Comment | 14 Sep, 2020
US-based Fitbit has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as...Read more
Oxford vaccine AZD1222 resumes clinical trial
World | News | 0 Comment | 14 Sep, 2020
Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...Read more
Cytiva invests $500M for global capacity expansion
World | News | 0 Comment | 14 Sep, 2020
Cytiva, a global life sciences leader, is expanding its manufacturing capacity and hiring personnel in key areas to supp...Read more
'Building a resilient healthcare system for post-COVID world': Expert Opinion
World | Opinion | 0 Comment | 11 Sep, 2020
“The post COVID-19 world will see an influx of information and research to cope with evolving healthcare needs. Th...Read more
Merck announces €59 M expansion of manufacturing capabilities
World | News | 0 Comment | 11 Sep, 2020
Merck has announced a € 59 million expansion of its Highly potent active pharmaceutical ingredients (HPAPI) and&nbs...Read more
"Uncovering the Role of Digital Technology in Tackling Covid-19", report by Rockefeller
World | News | 0 Comment | 10 Sep, 2020
The Rockefeller Foundation and ACCESS Health International on 9 Sep 2020 launched a new report on the important rol...Read more
AstraZeneca puts Ph III trials on hold for Oxford COVID-19 vaccine
World | News | 0 Comment | 09 Sep, 2020
AstraZeneca has temporarily put on hold the Phase III study of the University of Oxford COVID-19 vaccine following an un...Read more